Skip to main content
. 2021 Apr 23;5(8):2229–2236. doi: 10.1182/bloodadvances.2021004286

Table 3.

Hospital admissions according to age and dose intensity

Characteristic Age 70-79 y Age ≥80 y All patients (N = 690)
IDI ≥80% (n = 299) IDI <80% (n = 153) IDI ≥80% (n = 35) IDI <80% (n = 203)
Cycles of R-CHOP*
 Total 1674 802 171 1030 3677
 Mean 5.6 5.2 4.9 5.1 5.3
Admissions per cycle
 Total (%)* 335 (20.0) 184 (22.9) 48 (28.1) 230 (22.3) 797 (21.7)
 Mean 22.1 29.2 34.6 30.8 26.9
Admissions*
 Median (range) 1 (0-9) 1 (0-6) 1 (0-7) 1 (0-9) 1 (0-9)
 Mean 1.1 1.2 1.4 1.1 1.2
Admissions during chemotherapy for infection
 Yes 98 (33.0) 40 (26.1) 11 (32.4) 43 (21.3) 192 (28.0)
 No 199 (67.0) 113 (73.9) 23 (67.6) 159 (78.7) 494 (72.0)
 Missing 2 0 1 1 4
Total cumulative inpatient days
 Median (range) 2 (0-146) 5 (0-120) 5 (0-56) 2 (0-92) 2 (0-146)
 Mean 8.1 13.3 10.1 11.9 10.5
All-cause admissions
 Yes 164 (55.0) 97 (63.4) 20 (57.1) 116 (57.1) 397 (57.6)
 No 135 (45.3) 56 (36.6) 15 (42.9) 87 (42.9) 293 (42.5)
 Missing 0 0 0 0 0
Cycle 1 of R-CHOP received as inpatient
 Yes 73 (24.5) 67 (43.8) 9 (26.5) 72 (35.6) 221 (32.2)
 No 225 (75.5) 86 (56.2) 25 (73.5) 130 (64.4) 466 (67.8)
 Missing 1 0 1 1 3
Common causes of admission (mean rate % per cycle)*
 Neutropenic fever 118 (7.9) 29 (3.9) 10 (7.4) 23 (2.9) 180 (5.5)
 Non-neutropenic infection or fever 59 (3.8) 32 (5.8) 9 (5.2) 47 (6.0) 147 (4.9)
 Abdominal pain or distension 12 (0.7) 6 (1.2) 2 (1.0) 2 (0.2) 22 (0.7)
 Electrolyte or metabolic abnormality 5 (0.3) 8 (1.2) 0 3 (0.2) 16 (0.5)

Data are presented as n (%) unless otherwise specified.

*

Excluding patients with unknown >0 infection-related admissions.